
Anand Vaidya MD
Adrenal Disease
Associate Professor in Medicine, Brigham and Women's Hospital
Join to view full profile
55 Fruit StBoston, MA 02114
Phone+1 617-724-3782
Dr. Vaidya is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2008 - 2011
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2005 - 2008
Harvard Medical SchoolClass of 2005
Certifications & Licensure
MA State Medical License 2007 - 2028
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2014, 2016-2017
Clinical Trials
- Calcium Channel Blockade in Primary Aldosteronism Start of enrollment: 2020 Sep 01
Publications & Presentations
PubMed
- Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.Jun Yang, Jessica Goi, Jacopo Burrello, Martin Reincke, Christian Adolf
Hypertension. 2026-09-01 - Screening and diagnosis trends for primary aldosteronism: a longitudinal nationwide study of 7.8 million people.Cheng-Hsuan Tsai, Yu-Ching Chang, Zheng-Wei Chen, Stefanie Parisien-La Salle, Jenifer M Brown
European Journal of Endocrinology. 2026-08-03 - 1 citationsSubclinical Primary Aldosteronism and eGFR Decline Over Time.Gregory L Hundemer, Louis-Charles Desbiens, Mohsen Agharazii, François Madore, Anand Vaidya
Journal of the American Society of Nephrology. 2026-08-01
Press Mentions
A Can't-miss Cause of Resistant HypertensionMay 17th, 2021
Lying in Wait: The Hidden Threat of Primary AldosteronismDecember 1st, 2020- MANAGEMENT OF ENDOCRINE DISEASE: The Role of Surgical Adrenalectomy in Primary AldosteronismOctober 22nd, 2020
Grant Support
- Training Grant in Academic EndocrinologyBRIGHAM AND WOMEN'S HOSPITAL1985–2031
- Unrecognized Primary Aldosteronism as a Pathogenic Mechanism for Chronic Kidney Disease in DiabetesBRIGHAM AND WOMEN'S HOSPITAL2018–2029
- Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in ObesityBRIGHAM AND WOMEN'S HOSPITAL2020–2025
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









